GreenRoc now on the EU radar after presentation on Amitsoq at the Greenland Business Mission. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.45
Bid: 1.40
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.10 (7.143%)
Open: 1.45
High: 1.45
Low: 1.45
Prev. Close: 1.45

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Updates: Northern Leaf & OTO

8 Sep 2023 12:15

RNS Number : 8954L
Seed Innovations Limited
08 September 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

8 September 2023 

 

SEED Innovations Limited

 

("SEED" or the "Company")

 

Investee Company Updates:

Northern Leaf & OTO International

 

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies, to which, in normal circumstances, they have limited access to, today provides updates from two portfolio companies, Northern Leaf plc ("Northern Leaf") and OTO International Limited ("OTO").

 

Northern Leaf

 

Northern Leaf, a Jersey based medical cannabis producer, has provided a positive shareholder update in respect of recent progress both operationally and financially.

 

 

· Following receipt in May 2023 of Good Manufacturing Practice (GMP) accreditation by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for its flower product as an active pharmaceutical ingredient[1] in June 2023 Northern Leaf was accredited Good Agricultural and Collecting Practice by Control Union Medical Cannabis Standard (IMC- G.A.P) for its cultivation facility in Jersey. Northern Leaf expects this will enable it to sell into the rapidly growing Israeli medical cannabis market[2].

 

· Supply agreements have been received for initial sales into Germany and Australia, with a number of other supply agreements into various jurisdictions under discussion.

 

· Raised a further at least £1 million of pre-IPO money in addition to the £3 million pre-IPO fundraise earlier in 2023. This latest round is via a Loan Note with discretionary rights to convert at a percentage discount to a future IPO price and remains open until mid-September for final subscriptions, therefore there may be an increase to the overall raise.

 

· This additional fundraise provides further working capital to the business as work towards a possible AIM IPO continues.

 

 

The Company owns 1,236,331 ordinary shares in Northern Leaf representing 2.2% of Northern Leaf's issued share capital before this latest funding.

 

Commenting, Ed McDermott, CEO of SEED said:

"I am pleased to share Northern Leaf's recent developments. As a company focussed on becoming a key player in the European medical cannabis supply chain, the addition of GACP accreditation to the Home Office permissions and GMP accreditation already granted, puts Northern Leaf in a good position to sell products more widely, already evidenced with an uptick in supply agreements with a number expected to follow.

"To date, Northern Leaf has delivered on its plans and with additional pre-IPO funding also secured and work towards an AIM IPO picking up pace, we believe that Northern Leaf has potential to deliver real growth to our portfolio."

 

 

OTO

SEED updates shareholders on portfolio company OTO, the omni-channel premium wellness brand known for its use of holistic plant ingredients and CBD, following their purchase of former portfolio company, South West Brands Limited ("SWB") (announced via RNS 20 April 2023). OTO's acquisition of SWB further diversified OTO's business.

OTO has recently undertaken a fundraise to fund working capital through to the end of 2023 through the issue of a convertible instrument with both floor and ceiling prices for conversion at a significant discount (70% to 90%) to the £29.5M indicative enterprise value reported for OTO post the SWB purchase. Whilst repayments of the SWB Convertible Loan Note held by SEED, totalling £167,000, have commenced, with full repayment expected in the foreseeable future, SEED is taking a cautious and prudent valuation approach and impairing the combined loan and equity position by approximately 75% in light of both the tough current market conditions and likely needs of OTO to raise further funding in 2024. It is the hope of SEED that this valuation will be able to be increased again in the future once the business and environment at OTO improves.

As at 31 March 2023, the SWB position was valued (based on the anticipated OTO transaction) at £590K (equity £423K and loan of £167K). We currently expect that this will be reduced to circa. £146K in SEED's interim financial statements as at 30 September 2023 (represented by £38K in equity and £108K loans). This revaluation will reflect repayments made on the loan of £12,500 and write-down of the investment value of £431,500, being approximately 3% of the carrying net asset value of SEED's investments as at 31 March 2023.

Further commenting, Ed McDermott, added:

"We are disappointed to note the dilution resulting from a down round at OTO so soon after the acquisition of our original investment SWB. We acknowledge the challenges of raising capital in the current market environment and are hopeful that OTO has secured the funds it needs at this point. We understand that OTO is making some good progress operationally and we hope to share altogether more positive updates soon. SEED has adjusted the valuation of OTO equity against our NAV at this time but maintain the expectation for the eventual full repayment of our loan, albeit within a lengthened timeframe."

 

- Ends -

 

 

For further information on the Company please visit: www.seedinnovations.co or contact: 

 

 Ed McDermott 

Lance de Jersey 

SEED Innovations Ltd 

E: info@seedinnovations.co

James Biddle 

Roland Cornish 

Beaumont Cornish Limited, 

Nomad 

T: (0)20 7628 3396 

Isabella Pierre 

Damon Heath 

Shard Capital Partners LLP 

Broker 

T: (0)20 7186 9927 

Catherine Leftley 

Ana Ribeiro

Isabelle Morris 

 

St Brides Partners Ltd, 

Financial PR 

E: info@stbridespartners.co.uk 

Notes 

 

Seed Innovations Ltd 

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each. 

 

 

 

 

 


[1] https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=4340830&lang=en-GB&companycode=uk-kul&v=r2021).

[2] Source: https://knb.is/45QwzWk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUUGBUPWGGR
Date   Source Headline
24th Sep 20247:00 amRNSAGM Statement
2nd Sep 202412:35 pmRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSNotice of AGM
29th Aug 20247:00 amRNSDirector Share Purchase
16th Aug 20242:55 pmRNSChange of Registered Address
7th Aug 202411:40 amRNSNew Investment: Pantheon Resources plc
30th Jul 20242:39 pmRNSHolding(s) in Company
23rd Jul 20247:00 amRNSInvestee Company Update: Little Green Pharma Ltd
19th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSCompletion of share buy-back programme
31st May 20245:29 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th May 20244:34 pmRNSTransaction in Own Shares & TVR
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares & TVR
22nd May 202411:51 amRNSTransaction in Own Shares & TVR
21st May 20247:00 amRNSTransaction in Own Shares & TVR
20th May 20247:00 amRNSTransaction in Own Shares & TVR
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares & TVR
14th May 202412:52 pmRNSTransaction in Own Shares
13th May 20241:51 pmRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares & TVR
3rd May 20244:06 pmRNSTransaction in Own Shares & TVR
3rd May 20247:00 amRNSTransaction in Own Shares & TVR
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares & TVR
26th Apr 20244:46 pmRNSTransaction in Own Shares
25th Apr 202411:03 amRNSTransaction in Own Shares
24th Apr 20243:14 pmRNSTransaction in Own Shares & TVR
23rd Apr 202411:11 amRNSTransaction in Own Shares
22nd Apr 202411:33 amRNSTransaction in Own Shares
19th Apr 202410:55 amRNSTransaction in Own Shares & TVR
18th Apr 20241:20 pmRNSTransaction in Own Shares
17th Apr 20242:57 pmRNSInvestee Company Update: Little Green Pharma Ltd
17th Apr 202411:55 amRNSTransaction in Own Shares & TVR
16th Apr 20247:00 amRNSSpecial Dividend Declaration
15th Apr 20243:20 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSReceipt of remaining £2.4m from sale of Leap
12th Apr 20247:00 amRNSTransaction in Own Shares & TVR
9th Apr 20241:00 pmRNSInvestee Company Update: Northern Leaf plc
8th Apr 202412:20 pmRNSTransaction in Own Shares & TVR
5th Apr 20248:25 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:34 pmRNSTransaction in Own Shares & TVR
26th Mar 20241:03 pmRNSTransaction in Own Shares
26th Mar 20247:48 amRNSInvestee Company Update: Clean Food Group
25th Mar 20243:40 pmRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.